In conclusion, anti-CD4 CAR CD8-LVs were able to convert CD8 T cells into powerful cytotoxic T cells that lysed the CD4 cancer T cells in murine AITL biopsies. This evidence concerns the gene CD8A and angioimmunoblastic T-cell lymphoma.